EAAT2 dysfunction, associated with higher ambient glutamate levels, has been observed in neurodegenerative and psychiatric diseases including Huntington's, Parkinson's, Alzheimer's and schizophrenia in which cognitive functions are impaired7, 10, 11. This evidence concerns the gene SLC1A2 and Parkinson disease.